HPS-4/TIMI 65/ORION-4: A double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People with Atherosclerotic Cardiovascular Disease

Grant

Awarded By

Total Award Amount

  • 112092.00

    • Direct Costs

  • 82420.00

    • Sponsor Award Id

    • Contributor

  • Elizabeth Jackson   Investigator  
  • Vera Bittner   Principal Investigator